# Ballantyne Therapeutics, Inc. — Form D

Ballantyne Therapeutics, Inc. of CHARLOTTE, NC, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-14. The offering totals $500K, of which $400K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2015-07-14
- Form: D
- Accession: 0001645966-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $400K
- Remaining: $100K
- Investors: 7
- Date of first sale: 2015-05-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-243626

## Issuer

- Name: Ballantyne Therapeutics, Inc.
- CIK: 0001645966
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 13850 Ballantyne Corporate Place, CHARLOTTE, NC, 28277
- Phone: 704-887-3422

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Michael Roberts | Director | Roswell, GA |
| Michael Roberts | Executive Officer | Roswell, GA |
| Simon Pedder | Director | Charlotte, NC |
| Brian E Doxtator | Director | Charlotte, NC |
| Donald R Reynolds | Director | Charlotte, NC |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2015-10-22](https://search.stillhousedata.com/formd/0001586429-15-000002) | D/A | $800K | $565K |

## More

- [CIK 1645966 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1645966&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001645966-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.